Key result
Mutations in sarcomeric proteins cause around 20 different skeletal muscle diseases, highlighting the need for further research to decipher pathogenesis and develop effective therapies.
Mutations in sarcomeric proteins are responsible for approximately 20 skeletal muscle diseases, highlighting the need for further research into pathogenesis and therapies.
Alerts clinicians to sarcomeric myopathies in differentials; leaves open mechanistic studies and targeted therapies.
The sarcomere is the functional unit of striated muscle contraction. Mutations in sarcomeric proteins are now known to cause around 20 different skeletal muscle diseases. The diseases vary in severity from paralysis at birth, to mild conditions compatible with normal life span. The identification of the disease genes allows more accurate diagnosis, including prenatal diagnosis. Although many disease genes have been identified, the pathophysiology of the gene defects remains remarkably obscure, considering that many of the proteins have been researched for decades. The short-term goals are to determine the remaining disease genes and to decipher pathogenesis. The long-term goal is to develop effective therapies-a daunting task when humans are up to 40% muscle and the mutated proteins are fundamental to muscle contraction. The affected patients and families hope for help sooner rather than later. The onus is on all scientists researching sarcomeric proteins to help develop treatments.
No takes yet. Share an insight, caveat, or question.
Nigel G. Laing (2005) conducted a review in Skeletal muscle disease. Mutations in sarcomeric proteins was evaluated. Mutations in sarcomeric proteins cause around 20 different skeletal muscle diseases, highlighting the need for further research to decipher pathogenesis and develop effective therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: